Candriam SCA’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-219,575
| Closed | -$11.5M | – | 876 |
|
|
2020
Q3 | $11.5M | Sell |
219,575
-187,445
| -46% | -$9.84M | 0.11% | 207 |
|
|
2020
Q2 | $13.5M | Buy |
+407,020
| New | +$13.5M | 0.14% | 168 |
|
|
2018
Q4 | – | Sell |
-396,300
| Closed | -$10.4M | – | 863 |
|
|
2018
Q3 | $10.4M | Sell |
396,300
-40,200
| -9% | -$1.06M | 0.14% | 185 |
|
|
2018
Q2 | $8.93M | Buy |
436,500
+78,500
| +22% | +$1.61M | 0.14% | 186 |
|
|
2018
Q1 | $6.5M | Buy |
358,000
+11,000
| +3% | +$200K | 0.11% | 233 |
|
|
2017
Q4 | $4.84M | Sell |
347,000
-75,000
| -18% | -$1.05M | 0.08% | 272 |
|
|
2017
Q3 | $7.81M | Buy |
422,000
+55,000
| +15% | +$1.02M | 0.14% | 184 |
|
|
2017
Q2 | $6.2M | Buy |
367,000
+157,000
| +75% | +$2.65M | 0.12% | 209 |
|
|
2017
Q1 | $2.8M | Buy |
210,000
+140,000
| +200% | +$1.87M | 0.05% | 374 |
|
|
2016
Q4 | $1.05M | Hold |
70,000
| – | – | 0.02% | 507 |
|
|
2016
Q3 | $818K | Buy |
+70,000
| New | +$818K | 0.02% | 529 |
|